Lipoprotein(a) as a coronary risk factor in Japanese patients with Type II (non-insulin-dependent) diabetes mellitus. Relation with apolipoprotein(a) phenotypes.
Murakami
K
K
Ishibashi
S
S
Yoshida
Y
Y
Yamada
N
N
Akanuma
Y
Y
D001053:Apolipoproteins / Q000235:genetics*; D053241:Apoprotein(a); D003327:Coronary Disease / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000188:drug therapy / Q000235:genetics*; D003927:Diet, Diabetic; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007564:Japan; D017270:Lipoprotein(a) / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D012307:Risk Factors
D001053:Apolipoproteins; D007004:Hypoglycemic Agents; D000960:Hypolipidemic Agents; D017270:Lipoprotein(a); D053241:Apoprotein(a)